D. E. Siyutkin et al. / Tetrahedron Letters 49 (2008) 1212–1216
1215
7. (a) List, B.; Pojarliev, P.; Castello, C. Org. Lett. 2001, 3, 573; (b)
Chandrasekhar, S.; Narsihmulu, C.; Reddy, N. R.; Sultana, S. S.
Chem. Commun. 2004, 2450; (c) Amedjkouh, M. Tetrahedron:
Asymmetry 2005, 16, 1411.
8. (a) Welton, T. Chem. Rev. 1999, 99, 2071; (b) Wasserscheid, P.;
Welton, T. Ionic liquids in Synthesis 2003, 363; (c) Cordova, A.
Tetrahedron Lett. 2004, 45, 3949; (d) Gruttadauria, M.; Riela, S.;
Meo, P. L.; D’Anna, F.; Noto, R. Tetrahedron Lett. 2004, 45, 6113;
(e) Guo, H.-M.; Cun, L.-F.; Gong, L.-Z.; Mi, A.-Q.; Jiang, Y.-Z.
Chem. Commun. 2005, 1450; (f) Lombardo, M.; Pasi, F.; Easwar, S.;
Trombini, C. Adv. Synth. Catal. 2007, 349, 2061.
9. (a) Darbre, T.; Machuqueiro, M. Chem. Commun. 2003, 1090; (b)
Chimni, S. S.; Mahajan, D.; Suresh Babu, V. V. Tetrahedron Lett.
2005, 46, 5617; (c) Guilenna, G.; Hita, M. C.; Najera, C. Tetrahedron:
Asymmetry 2006, 17, 729–733; (d) Guillena, G.; Hita, M. C.; Najera,
C. Tetrahedron: Asymmetry 2006, 17, 1493; (e) Chimni, S. S.;
Mahajan, D. Tetrahedron: Asymmetry 2006, 17, 2108; (f) Chen,
X.-H.; Luo, S.-W.; Tang, Z.; Cun, L.-F.; Mi, A.-Q.; Jiang, Y.-Z.;
Gong, L.-Z. Chem. Eur. J. 2007, 13, 689; (g) Luo, S.; Mi, X.; Zhang,
L.; Liu, S.; Xu, H.; Cheng, J.-P. Tetrahedron 2007, 63, 1923.
10. (a) Mase, N.; Nakai, Y.; Ohara, N.; Yoda, H.; Takabe, K.; Tanaka,
F., ; Barbas, C. F., III. J. Am. Chem. Soc. 2006, 128, 734; (b) Wu, Y.;
Zhang, Y.; Yu, M.; Zhao, G.; Wang, S. Org. Lett. 2006, 8, 4417; (c)
Font, D.; Jimeno, C.; Pericas, M. A. Org. Lett. 2006, 8, 4653; (d)
Giacalone, F.; Gruttadauria, M.; Marculescu, A. M.; Noto, R.
Tetrahedron Lett. 2007, 48, 255; (e) Amedjkouh, M. Tetrahedron:
Asymmetry 2007, 18, 390; (f) Wu, X.; Jiang, Z.; Shen, H.-M.; Lu, Y.
Adv. Synth. Catal. 2007, 349, 812; (g) Teo, Y.-C. Tetrahedron:
Asymmetry 2007, 18, 1155; (h) Guizzetti, S.; Benaglia, M.; Raimondi,
L.; Celentano, G. Org. Lett. 2007, 9, 1247; (i) Gryko, D.; Saletra, W.
J. Org. Biomol. Chem. 2007, 5, 2148; (j) Wang, C.; Jiang, Y.; Zhang,
X.; Huang, Y.; Li, B.; Zhang, G. Tetrahedron Lett. 2007, 48, 4281; (k)
Huang, J.; Zhang, X.; Armstrong, D. W. Angew. Chem., Int. Ed. 2007,
46, 9073.
18. de Savignac, A.; Roques, C.; Hinedi, M.; Michel, G.; Lattes, A. Eur.
J. Med. Chem. Chim. Ther. 1990, 25, 449.
19. 1-(5-((1,5-Bis((benzyloxy)carbonyl)pyrrolidin-3-yl)oxy)-5-oxopentyl)-
3-dodecyl-1H-imidazol-3-ium bromide (6). A mixture of compound 5
(1.10 g, 2.12 mmol) and 1-(n-dodecyl)imidazole (0.60 g, 2.54 mmol)
was heated at 90 °C for 10 min, cooled to 20 °C and washed with Et2O
(6 ꢁ 15 ml). The residue was dissolved in MeOH (3 ml), and Et2O
(15 ml) was gradually added to the stirred solution. The separated oil
was dried in vacuo (0.5 Torr) for 2 h to afford compound 6 (1.13 g,
19
1
71%) as a yellow viscous oil; ½aꢂD ꢀ17.1 (c 1.33, CH3OH); H NMR
(300 MHz, CDCl3), d: 10.72 (1H, s, NCHN), 7.16–7.39 (12H, m, Ph,
NCHCHN), 5.27 (1H, s, CHO), 4.98–5.23 (4H, m, CH2Ph), 4.24–4.54
(5H, m, CH2CH2N, CH2CHN), 3.61–3.82 (2H, m, CHCH2N), 2.40
(2H, t, J = 7.3 Hz, CH2CH2COO), 2.17–2.51 (2H, m, CH2CHN),
1.84–2.02 (4H, m, CH2CH2N), 1.59–2.71 (2H, m, CH2CH2COO),
1.21–1.38 (18H, m, CH3(CH2)9), 0.88 (3H, t, J = 6.8 Hz, CH3) ppm;
13C NMR (75 MHz, CDCl3), d: 172.13, 171.58, 154.28, 136.61,
136.01, 135.08, 128.40, 128.31, 128.18, 127.98, 127.90, 127.63, 122.27,
121.83, 72.13, 67.14, 66.86, 57.67, 52.19, 49.93, 49.31, 35.78, 32.94,
31.68, 30.08, 29.47, 29.39, 29.31, 29.19, 29.12, 28.81, 26.07, 22.47,
21.04, 13.94 ppm. Anal. Calcd for C40H56BrN3O6: C, 63.65; H, 7.48;
N, 5.57; Br, 10.59. Found: C, 63.82; H, 7.41; N, 5.69; Br, 10.48.
20. 4-((5-(3-Dodecyl-1H-imidazol-3-ium-1-yl)pentanoyl)oxy)proline bromide
(7). A mixture of compound 6 (1.13 g, 1.50 mmol), Pd/C (5%)
(0.11 mg), and dry CH3OH (35 ml) was stirred under H2 (760 Torr) at
ambient temperature for 2 h. The resulting precipitate was filtered off,
and the filtrate was evaporated in vacuo. The residue was dissolved in
MeOH (2.5 ml), and Et2O (12 ml) was gradually added to the stirred
solution. The separated oil was dried in vacuo (0.5 Torr) for 2 h to
19
afford amino acid 7 (0.70 g, 87%) as a pale yellow oil; ½aꢂD ꢀ13.2 (c
1.22, CH3OH); 1H NMR (300 MHz, DMSO-d6) d: 9.26 (1H, s,
NCHN), 7.82 (2H, s, NCHCHN), 5.18–5.23 (1H, m, CHO), 4.11–4.22
(4H, m, CH2CH2N), 3.80 (1H, t, J = 8.9 Hz, CH2CHN), 3.08–3.50
(2H, m, CHCH2N), 2.37 (2H, t, J = 6.6 Hz, CH2CH2COO), 2.04–2.23
(2H, m, CH2CHN), 1.72–1.88 (4H, m, CH2CH2N), 1.43–1.55 (2H, m,
CH2CH2COO), 1.22 (18H, s, CH3(CH2)9), 0.85 (3H, t, J = 6.1 Hz,
CH3) ppm; 13C NMR (75 MHz, DMSO-d6), d: 172.07, 169.90, 136.04,
122.49, 122.44, 73.25, 59.37, 49.91, 48.88, 48.49, 35.06, 32.58, 31.32,
29.34, 29.04, 28.96, 28.85, 28.74, 28.68, 28.38, 25.53, 22.11, 20.72,
13.93 ppm. Anal. Calcd for C25H44BrN3O4: C, 56.60; H, 8.36; N, 7.92;
Br, 15.06. Found: C, 56.79; H, 8.29; N, 8.03; Br, 14.91.
11. (a) Narayan, S.; Muldoon, J.; Finn, M. G.; Fokin, V. V.; Kolb, H. C.;
Sharpless, K. B. Angew. Chem., Int. Ed. 2005, 44, 3275; (b) Jung, Y.;
Marcus, R. A. J. Am. Chem. Soc. 2007, 129, 5492.
12. Brogan, A. P.; Dickerson, T. J.; Janda, K. D. Angew. Chem., Int. Ed.
2006, 45, 8100.
13. (a) Guillena, G.; del Carmen Hita, M.; Najera, C. Tetrahedron:
Asymmetry 2006, 17, 1493; (b) Peng, Y.-Y.; Ding, Q.-P.; Li, Z.; Wang,
P. G.; Cheng, J.-P. Tetrahedron Lett. 2003, 44, 3871; (c) Lei, M.; Shi,
L.; Li, G.; Chen, S.; Fang, W.; Ge, Z.; Cheng, T.; Li, R. Tetrahedron
2007, 63, 7892.
21. 4-((5-(3-Dodecyl-1H-imidazol-3-ium-1-yl)pentanoyl)oxy)proline tetra-
fluoroborate (2). A solution of AgBF4 (0.24 g, 1.23 mmol) in CH3OH
(5 ml) was gradually added to a stirred solution of amino acid 7
(0.65 g, 1.23 mmol) in the same solvent (5 ml). The resulting precip-
itate was filtered off and washed with CH3OH (5 ml). The combined
organic extracts were evaporated, and the residue was dried in vacuo
(0.5 Torr) for 2 h to afford tetrafluoroborate 2 (0.64 g, 98%) as
14. Li, C.-J. Chem. Rev. 2005, 105, 3095.
15. Miao, W.; Chan, T. H. Adv. Synth. Catal. 2006, 348, 1711.
16. Tamaki, M.; Han, G.; Hruby, V. J. J. Org. Chem. 2001, 66, 1038.
17. Dibenzyl 4-((5-bromopentanoyl)oxy)pyrrolidine-1,2-dicarboxylate (5).
A mixture of compound 416 (4.01 g, 11.30 mmol), 5-bromovaleric acid
(2.09 g, 11.55 mmol), DCC (2.38 g, 11.55 mmol), DMAP (20 mg,
0.16 mmol), and CH2Cl2 (60 ml) was stirred at 5 °C for 3 h. The
resulting precipitate was filtered off and washed with CH2Cl2
(3 ꢁ 10 ml). The combined organic extracts were washed successively
with 35% HCl (2 ꢁ 15 ml) and distilled water (2 ꢁ 20 ml). The solvent
was evaporated in vacuo, and the residue was purified by column
19
colorless hydroscopic crystals, mp 117–119 °C; ½aꢂD ꢀ11.8 (c 1,
CH3OH); 1H NMR (300 MHz, DMSO-d6), d: 9.19 (1H, s, NCHN),
7.79 (2H, s, NCHCHN), 5.17–5.23 (1H, m, CHO), 4.11–4.21 (4H, m,
CH2CH2N), 3.81 (1H, t, J = 8.9 Hz, CH2CHN), 3.08–3.50 (2H, m,
CHCH2N), 2.36 (2H, t, J = 6.6 Hz, CH2CH2COO), 2.05–2.23 (2H, m,
CH2CHN), 1.73–1.86 (4H, m, CH2CH2N), 1.43–1.54 (2H, m,
CH2CH2COO), 1.23 (18H, s, CH3(CH2)9), 0.85 (3H, t, J = 6.1 Hz,
CH3) ppm; 13C NMR (75 MHz, DMSO-d6), d: 172.07, 169.90, 136.04,
122.49, 122.44, 73.25, 59.37, 49.91, 48.88, 48.49, 35.06, 32.58, 31.32,
29.34, 29.04, 28.96, 28.85, 28.74, 28.68, 28.38, 25.53, 22.11, 20.72,
13.93 ppm; 11B NMR (64.21 MHz, DMSO-d6), d: ꢀ1.08 ppm; 19F
NMR (188.31 MHz, DMSO-d6), d: ꢀ147.6 ppm. Anal. Calcd for
˚
chromatography on silica gel (Acros, 60–200 lm, 60 A, eluent
n-hexane/EtOAc 4:1) to afford compound 5 (4.73 g, 80%) as a
23
colorless viscous oil; ½aꢂD ꢀ30.2 (c 1, CHCl3); 1H NMR (300 MHz,
CDCl3), d: 7.18–7.43 (10H, m, Ph), 5.30 (1H, s, CHO), 4.98–5.27 (4H,
m, PhCH2), 4.52 (1H, dt, J = 19.5, 7.7 Hz, CHCOO), 3.62–3.85 (2H,
m, CH2N), 3.41 (2H, t, J = 6.4 Hz, BrCH2), 2.15–2.49 (2H, m,
CHCH2CH), 2.33 (2H, t, J = 6.4 Hz, CH2CH2COO), 1.68–1.93 (4H,
m, BrCH2CH2CH2) ppm; 13C NMR (75 MHz, CDCl3), d: 172.32,
171.78, 154.34, 136.13, 135.22, 128.58, 128.54, 128.46, 128.27, 128.00,
127.83, 72.13, 67.25, 66.96, 57.77, 52.32, 36.51, 35.47, 33.07, 31.73,
23.20 ppm. Anal. Calcd for C25H28BrNO6: C, 57.92; H, 5.44; N, 2.70;
Br, 15.41. Found: C, 58.14; H, 5.31; N, 2.74; Br, 15.27. Rf = 0.35 (n-
hexane/ethyl acetate 3:1).
C
25H44BF4N3O4: C, 55.87; H, 8.25; N, 7.82; F, 14.14. Found: C,
56.05; H, 8.17; N, 7.68; F, 13.99.
22. 4-((5-(3-Dodecyl-1H-imidazol-3-ium-1-yl)pentanoyl)oxy)proline
hexafluorophosphate (3).
A solution of amino acid 7 (0.10 g,
0.19 mmol) in water (5 ml) was adjusted to pH ꢃ 2–3 with 60%
HPF6 (0.06 ml, 0.38 mmol) at 20 °C. The reaction mixture was then
adjusted to pH ꢃ 8–9 with 25% NH3. The resulting precipitate was
filtered off, and washed with water until the washings became neutral